Editor’s Picks: Xconomy Seattle’s Best Stories of 2012

When you work on news at Internet speed, it’s sometimes hard to remember what you did last week. Maybe that’s why I enjoy this annual ritual of sifting through the best journalism of the year that appeared on Xconomy Seattle. This task reminds me that we’ve published a lot of interesting, important, and exclusive stories about the innovation community in the Pacific Northwest.

Before diving into our best coverage of tech, biotech, and cleantech in 2012, I’d like to remind readers that we have a new face covering the news. A couple months ago, ace tech writer Curt Woodward transferred to the Xconomy Boston office. As Curt has been ramping up his coverage on the East Coast, we’ve had the pleasure of recruiting another terrific journalistic talent here in Seattle—Benjamin Romano.

Ben brings a rare mix of experience to this job, as a former Microsoft beat reporter for The Seattle Times and as a U.S. correspondent for Recharge, a clean energy publication. Even though he only started in late October, he has already delivered a couple stories strong enough to make the list you see below.

If you have any tips about people and companies on the Northwest tech and cleantech beats, please send them to [email protected]. Life sciences news and features are best sent to me at [email protected]. We look forward to delivering more quality journalism for the community in the year ahead. Thanks to all the readers and sponsors out there who have supported us in this great adventure in online journalism.

 

Top 12 tech and cleantech stories at Xconomy Seattle in 2012

UW Spinout Funded by Madrona To Build Cheap Home Sensor Networks

How 3Tier Wind Forecasts Enable the Northwest Smart Grid

Why a Microsoft Smartphone Just Can’t Happen—Not Yet, Anyway

Why Amazon Can Win in Mobile, While Microsoft Sputters

Amazon’s Fuzzy Math: Stop Encouraging Them

Zulily Quietly Powers Past 5M Members in Mom-and-Kid Sales

Nuance, Swype Combine Strengths—with an Eye On More than Mobile

Amazon Takes Over: How a Flood of People Could Remake Seattle

Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down

Northeastern Looks Northwest, Aims to Fill Voids in Tech Job Market

Amazon’s Fight Against Content Middlemen: Books, TV, Movies, Games

Voyager Co-Founder Godreau at New Firm with Ex-MS, Yahoo, AOL Execs

 

Top 12 biotech stories at Xconomy Seattle in 2012

The Few and the Proud: The Biotech Startup Class of 2012

Sarepta Moves From Seattle to Boston to Recruit More Talent

U.S. Biotech Clusters are Losing Their Anchor Tenants and It Hurts

A Lonely Voice Asking Tough Questions on Cancer Cost-Effectiveness

Allan Jones, The Force Behind Paul Allen’s Vision for Brain Science

Kona Medical Gets $30M to Zap High Blood Pressure With Ultrasound

Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3

2012: The Year When Genomic Medicine Started Paying Off

Alder Bipoharma Snags $38M to Push Ahead With Antibody Drugs

Sage Bionetworks Moves From Thinking Stage to Doing Stage

Dendreon CEO John Johnson: ‘This is My Last Stop’

Frazier Looks to Build Biotechs For Sale, Lay Groundwork for First Post-Crisis Fund

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.